Skip to content
Back to search

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Calcipotriol/Betamethason - Schaum (amtlicher ATC-Code: D05AX22)

AOK PLUS - Die Gesundheitskasse für Sachsen und ThüringenGermanyPublished on Mar 26, 2026
634 days left

Description

The subject of this publication is the conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for medicinal products with the active ingredient Calcipotriol/Betamethasone (official ATC code: D05AX22), limited to the foam dosage form. The contract will be concluded within the framework of a so-called Open-House model, i.e. a contract conclusion is open to all interested pharmaceutical companies within the participation period, provided that they meet and accept the participation requirements. This means that individual contract negotiations will not be conducted and there will be no (supply) exclusivity. It is pointed out that the procurement quantity is unknown, as it depends on demand and the development of the number of insured persons, the prescription behaviour of doctors, and the dispensing and stocking behaviour of public pharmacies. Accordingly, minimum procurement quantities are not guaranteed. Interested pharmaceutical companies can download the participation documents from the project room of the German Tender Portal (DTVP). To do this, an application for access to the project room is first required. After the applicant has been enabled by the contracting entity, the participation documents can be accessed. Absolute confidentiality must be maintained regarding the content of the participation documents - in particular regarding the content of the discount agreement and the rebates mentioned therein. Any full or partial disclosure or provision of contents of the participation documents to or for third parties requires the prior written consent of the contracting entity. If participation is waived, all documents must be destroyed immediately in accordance with data protection regulations. The documents to be submitted are set out in the documents "Letter" and "Explanations of the Contract Terms" deposited in the project room. Communication, including the transmission of the participation documents, will be conducted electronically via the tender portal DTVP; further details can be found in the aforementioned documents. Any contradictory information in the contract notice is due to technical reasons and is not binding. Participation applications can be submitted for the first time by 30 April 2026. All further submission deadlines can be found in the annex "Submission Deadlines" deposited in the project room. If the deadline for submission falls on a Saturday, Sunday or public holiday throughout Germany, the next working day will take its place. If the submission is received late, the submitted participation applications will be considered for the next submission deadline. The discount agreement will end, regardless of the date of the contract conclusion, at the latest on 31 May 2028. The contracting entity reserves the right to terminate the Open-House procedure prematurely, in particular in the event of the conclusion of exclusive discount agreements; in this case, the discount agreements already concluded will end in accordance with the contractual provisions. According to the contracting entity's experience, exclusive discount agreements generally come into force 8 to 12 months after the publication of the corresponding contract notice in the Supplement to the Official Journal of the European Union.

CPV codes

Pharmaceutical products

Documents & submission

AI summary
Sign in for an AI summary

Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.

Related tenders